| Literature DB >> 34250251 |
Chi-Fang Chen1, Tao-Yeuan Wang2,3, Marcelo Chen1,3, Yung-Chieh Lin4.
Abstract
Aggressive angiomyxoma (AAM) is a rare mesenchymal myxoid tumor, and most cases occur in the pelvic region or perineum of adult females. AAM is very rare in males. Most of these cases have been diagnosed in patients aged 30-60 years, and the tumors involved the pelvic cavity, scrotum, or spermatic cord. AAM can mimic inguinal hernia, hydrocele, or paratesticular neoplasm. Four male cases have been reported with paratesticular AAM mimicking a testicular/epididymal tumor, and to the best of our knowledge, this is the oldest patient in the literature. Because of its rarity, making an exact diagnosis before surgery is difficult. Herein, we present a case of AAM in an 82-year-old man and review the literature.Entities:
Keywords: AAM; deep angiomyxoma; mesenchymal tumor; older; paratesticular mass
Year: 2021 PMID: 34250251 PMCID: PMC8247787 DOI: 10.1515/med-2021-0317
Source DB: PubMed Journal: Open Med (Wars)
Figure 1Ultrasound sonography: (a) a well-capsulated heteroechoic round mass over the tail of epididymis, 4.7 × 3.5 cm in size, and (b) abundant tortuous vessels adjacent to the paratesticular tumor. (c) The tumor had a rich blood supply on color Doppler sonography.
Figure 2A white, grayish, well-circumscribed, solid tumor (4 × 3.5 cm) adherent to atrophic testis and epididymis (arrow: tumor; star: testis).
Figure 3Typical bland spindle or stellate cells with little or no nuclear polymorphism and variably elongated cytoplasm set in a mucomyxoid stroma. Vascularity was variably composed of delicate to more hyalinized vessels (a) (hematoxylin and eosin, magnification 200×); typical cytoplasmic desmin (b) and smooth muscle actin (c) immunopositivity (magnification 200×).
Clinical details of paratesticular angiomyxoma in a literature review
| Source (author) | Site | Age | Size (cm) | Treatment | Immunostaining results | Follow-up (NED/LR) |
|---|---|---|---|---|---|---|
| Chen et al.* | Paratestis | 82 | 4.7 × 3.5 | Orchiectomy | CD34, Desmin, SMA(+) S100, ER, PR(−) | NED (4 months) |
| Neyaz et al. [ | Paratestis | 53 | 15 × 10 | Orchiectomy | Vimentin, CD34, SMA(+) Desmin (focal+) S100, ER, PR(−) | NED (12 months) |
| Serao et al. [ | Paratestis | 72 | 7.7 × 5.6 | Orchiectomy | CD34, Desmin, Actin, PR(+), ER(−) | NED |
| Aydin et al. [ | Paratestis | 66 | 11 × 7.5 | Orchiectomy | CD34, ER, PR(+) SMA, S100 (−) | NED (6 months) |
| Ismail et al. [ | Paratestis | 65 | 11 × 8 | Orchiectomy | Desmin, SMA(+) ER (focal+) PR, CD34, S100(−) | NED (24 months) |
| Durdov et al. [ | Scrotum | 37 | 7 × 5 | Wide excision | Vimentin(+) Desmin(−) SMA(−) S100(−) | NED (24 months) |
| Chihara et al. [ | Scrotum | 47 | 17 × 10 | Wide excision | ER(focal+) PR(−) S100(−) HHF35(−) | NED (14 months) |
| Kirkilessis et al. [ | Scrotum | 57 | 11 | Wide excision | Desmin, CD34, SMA(+) ER(focal+) PR(focal+) | NED (24 months) |
Abbreviations: NED, no evidence of recurrence; LR, local recurrence; SMA, smooth muscle alpha-actin; ER, estrogen receptor; PR, progesterone receptor (*our case).